Medical Science News

RSS

New method integrates supercomputer simulation and experimental results

A theoretical technique developed at the Department of Energy's Oak Ridge National Laboratory is bringing supercomputer simulations and experimental results closer together by identifying common "fingerprints."

23 Feb 2011

PPD, Elan establish strategic collaboration to execute clinical programs

Elan, plc and PPD, Inc. today announced they have formed a global business collaboration focused on the advancement, progression and execution of Elan's development portfolio.

23 Feb 2011

New study: Portion of brain responsible for reading doesn't require vision at all

The portion of the brain responsible for visual reading doesn't require vision at all, according to a new study by researchers from the Hebrew University of Jerusalem and France.

23 Feb 2011

ETH scientists warn about impact of cell phone radiation in brain of healthy adults

Expert scientists working with Environmental Health Trust, a nonprofit research and educational group, say that new studies showing that cell phone radiation excites the brain strengthen the need for a major research program on cell phones and health, revamping approaches to setting standards, and putting warnings on cell phones.

23 Feb 2011

Stripe of Gennari in the blind may play greater role in processing tactile stimuli

The Stripe of Gennari develops even in those who are blind from birth and does not degenerate, despite a lack of visual input. This was discovered by Robert Trampel and colleagues from the Max Planck Institute for Human Cognitive and Brain Sciences using magnetic resonance imaging. This bundle of nerve fibers, which is approximately 0.3 mm thick, is not exclusively responsible for optic information.

23 Feb 2011

Knocking out genes completely and exclusively in Natural Killer cells

Our immune systems contain three fundamentally different types of cell: B-cells, T-cells and the mysteriously named Natural Killer cells (NK cells), which are known to be involved in killing tumour cells and other infected cells. Experiments to investigate the function of NK cells have proven difficult to interpret because the interactions between the various components of the immune system make it almost impossible to isolate effects of individual cell types.

23 Feb 2011

USPTO issues patent to Silence Therapeutics' siRNA technology

Silence Therapeutics plc announces the issuance of United States patent 7,893,245, titled "Interfering RNA Molecules," by the United States Patent and Trademark Office.

23 Feb 2011

Cerasome filled molecular-sized bubbles to target liver cancer cells

Nanotechnology may open a new door on the treatment of liver cancer, according to a team of Penn State College of Medicine researchers. They used molecular-sized bubbles filled with chemotherapy drugs to prevent cell growth and initiate cell death in test tubes and mice.

23 Feb 2011

Biochemist receives STAC grant to find treatment for C. albicans infection in premature infants

A $200,000 grant from the Rhode Island Science and Technology Advisory Council is helping a Bryant University biochemist find a treatment for a fungal infection that is often lethal to premature infants.

23 Feb 2011

Nanoparticle therapy may improve survival after life-threatening blood loss

In an advance that could improve battlefield and trauma care, scientists at Albert Einstein College of Medicine of Yeshiva University have used tiny particles called nanoparticles to improve survival after life-threatening blood loss.

23 Feb 2011

New DNA technology to study cystic fibrosis 'superbug' during infection

The bacterium, called Pseudomonas aeruginosa, is the most common cause of persistent and fatal lung infections in cystic fibrosis patients. Scientists at Liverpool identified a particularly virulent strain of the bacteria that is transmissible between patients. The Liverpool Epidemic Strain (LES), referred to as a cystic fibrosis 'superbug', can cause aggressive infection and results in progressive lung decline.

23 Feb 2011

Mechanism of cancer treatment related to infertility in women

Chemotherapeutic agents, used in cancer treatment, destroy not only cancer cells but also healthy cells, thus affecting germ cells as well. Consequently, after surviving cancer many female patients are confronted with the diagnosis: infertility. For a long time a relationship between infertility and chemotherapeutic agents has been assumed, but until now, the exact mechanism was not known.

23 Feb 2011

New nanoparticle can help develop vaccines against HIV, malaria

MIT engineers have designed a new type of nanoparticle that could safely and effectively deliver vaccines for diseases such as HIV and malaria.

23 Feb 2011

Researchers discover biological pathway that alters normal cells into aggressive tumors

A biological pathway that transforms normal cells into aggressive tumors has been discovered by researchers at Cleveland Clinic's Lerner Research Institute.

23 Feb 2011

Researchers to explore genomes of childhood cancers

In a project supported by Genome BC, a Vancouver pediatric pathologist at the BC Cancer Agency/University of British Columbia is leading the team that will explore the genomes of four of the most challenging childhood cancers known.

23 Feb 2011

New DNA microarray detects genetic changes differentiating cancer patients from healthy individuals

A group of researchers led by scientists from the Virginia Bioinformatics Institute at Virginia Tech have developed a new technology that detects distinct genetic changes differentiating cancer patients from healthy individuals and could serve as a future cancer predisposition test.

23 Feb 2011

Cancer-causing retrovirus prolongs survival of host cells

A cancer-causing retrovirus exploits key proteins in its host cells to extend the life of those cells, thereby prolonging its own survival and ability to spread, according to a new study by researchers at The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC - James) and Ohio State's College of Veterinary Medicine.

23 Feb 2011

Caliper Life Sciences, IntegenX enter license agreement for microfluidics patent portfolio

IntegenX Inc. and Caliper Life Sciences, Inc. today announced a license agreement providing IntegenX access to Caliper's microfluidics patent portfolio.

23 Feb 2011

Human umbilical cord blood-derived EPCs accelerate wound healing in diabetics

Transplanting human umbilical cord blood-derived endothelial progenitor cells (EPCs) has been found to "significantly accelerate" wound closure in diabetic mouse models, said a team of Korean researchers publishing in the current issue of Cell Transplantation.

23 Feb 2011

Breakthrough in Huntington's disease may give patients hope for cure

A huge leap forward in understanding Huntington's disease may give patients hope for a cure.

23 Feb 2011

Medical Science News

New method integrates supercomputer simulation and experimental results

PPD, Elan establish strategic collaboration to execute clinical programs

New study: Portion of brain responsible for reading doesn't require vision at all

ETH scientists warn about impact of cell phone radiation in brain of healthy adults

Stripe of Gennari in the blind may play greater role in processing tactile stimuli

Knocking out genes completely and exclusively in Natural Killer cells

USPTO issues patent to Silence Therapeutics' siRNA technology

Cerasome filled molecular-sized bubbles to target liver cancer cells

Biochemist receives STAC grant to find treatment for C. albicans infection in premature infants

Nanoparticle therapy may improve survival after life-threatening blood loss

New DNA technology to study cystic fibrosis 'superbug' during infection

Mechanism of cancer treatment related to infertility in women

New nanoparticle can help develop vaccines against HIV, malaria

Researchers discover biological pathway that alters normal cells into aggressive tumors

Researchers to explore genomes of childhood cancers

New DNA microarray detects genetic changes differentiating cancer patients from healthy individuals

Cancer-causing retrovirus prolongs survival of host cells

Caliper Life Sciences, IntegenX enter license agreement for microfluidics patent portfolio

Human umbilical cord blood-derived EPCs accelerate wound healing in diabetics

Breakthrough in Huntington's disease may give patients hope for cure

Leveraging the Radian ASAP in standard casework

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Latest News